Infection and Immunity, March 2005, p. 1706-1713, Vol. 73, No. 3
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.3.1706-1713.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Role of the Type III Secreted Exoenzymes S, T, and Y in Systemic Spread of Pseudomonas aeruginosa PAO1 In Vivo
Russell E. Vance,1,
Arne Rietsch,1,
and
John J. Mekalanos1*
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts1
Received 17 July 2004/
Returned for modification 6 October 2004/
Accepted 19 November 2004
Pseudomonas aeruginosa uses a dedicated type III secretion system to deliver toxins directly into the cytoplasm of host cells. While progress has been made in elucidating the function of type III-secreted toxins in vitro, the in vivo functions of the type III-secreted exoenzymes are less well understood, particularly for the sequenced strain PAO1. Therefore, we have systematically deleted the genes for the three known type III effector molecules (exoS, exoT, and exoY) in P. aeruginosa PAO1 and assayed the effect of the deletions, both singly and in combination, on cytotoxicity in vitro and in vivo. We found that the type III secretion system acts differently on different cell types, causing an exoST-dependent rounding of a lung epithelial-like cell line in contrast to causing an exoSTY-independent but translocase (popB)-dependent lysis of a macrophage cell line. We utilized an in vivo competitive infection model to test each of our mutants, examining replication in the lung and spread to secondary sites such as the blood and spleen. Type III mutants inoculated intranasally exhibited only a minor defect in replication and survival in the lung, but popB and exoSTY triple mutants were profoundly defective in their ability to spread systemically. Intravenous injection of the mutants indicated that the type III secretion machinery is required for survival in the blood. Furthermore, our findings suggest that the effector-independent popB-dependent cytotoxicity that we and others have observed in vitro in macrophage cell lines may not be of great importance in vivo.
* Corresponding author. Mailing address: 200 Longwood Ave., Armenise Building, Rm. 421, Boston, MA 02115. Phone: (617) 642-1935. Fax:. (617) 738-7664. E-mail: jmekalanos{at}hms.harvard.edu.
Editor: V. J. DiRita
R.E.V. and A.R. contributed equally to this study.
Infection and Immunity, March 2005, p. 1706-1713, Vol. 73, No. 3
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.3.1706-1713.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Angus, A. A., Lee, A. A., Augustin, D. K., Lee, E. J., Evans, D. J., Fleiszig, S. M. J.
(2008). Pseudomonas aeruginosa Induces Membrane Blebs in Epithelial Cells, Which Are Utilized as a Niche for Intracellular Replication and Motility. Infect. Immun.
76: 1992-2001
[Abstract]
[Full Text]
-
Cisz, M., Lee, P.-C., Rietsch, A.
(2008). ExoS Controls the Cell Contact-Mediated Switch to Effector Secretion in Pseudomonas aeruginosa. J. Bacteriol.
190: 2726-2738
[Abstract]
[Full Text]
-
Soong, G., Parker, D., Magargee, M., Prince, A. S.
(2008). The Type III Toxins of Pseudomonas aeruginosa Disrupt Epithelial Barrier Function. J. Bacteriol.
190: 2814-2821
[Abstract]
[Full Text]
-
Miao, E. A., Ernst, R. K., Dors, M., Mao, D. P., Aderem, A.
(2008). Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc. Natl. Acad. Sci. USA
105: 2562-2567
[Abstract]
[Full Text]
-
Scarff, J. M., Goldberg, J. B.
(2008). Vaccination against Pseudomonas aeruginosa Pneumonia in Immunocompromised Mice. CVI
15: 367-375
[Abstract]
[Full Text]
-
Sutterwala, F. S., Mijares, L. A., Li, L., Ogura, Y., Kazmierczak, B. I., Flavell, R. A.
(2007). Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med.
204: 3235-3245
[Abstract]
[Full Text]
-
Quinaud, M., Ple, S., Job, V., Contreras-Martel, C., Simorre, J.-P., Attree, I., Dessen, A.
(2007). Structure of the heterotrimeric complex that regulates type III secretion needle formation. Proc. Natl. Acad. Sci. USA
104: 7803-7808
[Abstract]
[Full Text]
-
Rawls, J. F., Mahowald, M. A., Goodman, A. L., Trent, C. M., Gordon, J. I.
(2007). In vivo imaging and genetic analysis link bacterial motility and symbiosis in the zebrafish gut. Proc. Natl. Acad. Sci. USA
104: 7622-7627
[Abstract]
[Full Text]
-
O'Grady, E. P., Mulcahy, H., O'Callaghan, J., Adams, C., O'Gara, F.
(2006). Pseudomonas aeruginosa Infection of Airway Epithelial Cells Modulates Expression of Kruppel-Like Factors 2 and 6 via RsmA-Mediated Regulation of Type III Exoenzymes S and Y.. Infect. Immun.
74: 5893-5902
[Abstract]
[Full Text]
-
Zolfaghar, I., Evans, D. J., Ronaghi, R., Fleiszig, S. M. J.
(2006). Type III Secretion-Dependent Modulation of Innate Immunity as One of Multiple Factors Regulated by Pseudomonas aeruginosa RetS. Infect. Immun.
74: 3880-3889
[Abstract]
[Full Text]
-
Mulcahy, H., O'Callaghan, J., O'Grady, E. P., Adams, C., O'Gara, F.
(2006). The Posttranscriptional Regulator RsmA Plays a Role in the Interaction between Pseudomonas aeruginosa and Human Airway Epithelial Cells by Positively Regulating the Type III Secretion System.. Infect. Immun.
74: 3012-3015
[Abstract]
[Full Text]
-
Furukawa, S., Kuchma, S. L., O'Toole, G. A.
(2006). Keeping Their Options Open: Acute versus Persistent Infections. J. Bacteriol.
188: 1211-1217
[Full Text]
-
Pukatzki, S., Ma, A. T., Sturtevant, D., Krastins, B., Sarracino, D., Nelson, W. C., Heidelberg, J. F., Mekalanos, J. J.
(2006). Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc. Natl. Acad. Sci. USA
103: 1528-1533
[Abstract]
[Full Text]
-
Shaver, C. M., Hauser, A. R.
(2006). Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals. Microbiology
152: 143-152
[Abstract]
[Full Text]
Copyright © 2005 by the American Society for Microbiology. All rights reserved.